ClinicalTrials.Veeva

Menu

Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus

O

Odense University Hospital

Status

Unknown

Conditions

Type 2 Diabetes Mellitus

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The study aim is to establish a consecutive population of newly referred type 2 diabetes mellitus patients and among these to describe the degree of macrovascular disease by evaluating left ventricular systolic and diastolic function (echocardiography), myocardial perfusion (single-photon emission computed tomography (SPECT)), the peripheral vascular perfusion (strain gauge toe blood pressure measurements and a ultrasound scan of the a. carotis communis). Further, the degree of microvascular disease will be evaluated (glomerular filtration rate assessment, fundus photography and biotesiometry). Finally the cohort will be followed the next two years to assess the prognostic value of the above-mentioned parameters

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: ≥ 20 years.
  • Fasting C-peptide > 300 pmol/l.

Exclusion criteria

  • Verified medical history of macrovascular disease (stroke, myocardiac infarct, coronary revascularisation or strain gauge toe blood pressure < 30 mmHg).
  • Suspected short lifespan because of malignant disease or end-stage kidney disease.
  • Pregnancy or planned pregnancy during the study period.
  • Body weight > 150 kg.
  • Physical or mental disability not enabling participation in the study.

Trial contacts and locations

1

Loading...

Central trial contact

Jan E. Henriksen, MD, PhD; Mikael K. Poulsen, PhD student

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems